New supramolecular alzheimers drugs | Chemistry World - Supramolecular chemistry could provide a new avenue in the treatment of Alzheimer’s disease, say scientists in China. The group demonstrates for the first time that supramolecular complexes can inhibit the aggregation of a peptide thought to cause Alzheimer’s disease.
(10.1039/c2sc20372c)Email Newsletter
David Bradley
Slinn Pickings
ChemSpy.com is owned and operated by science journalist David Bradley. Additional chemistry news updates are posted by chemist Robert Slinn CChem MRSC MPhil with the tag: Slinn Pickings.
About